spacer
home > ebr > summer 2003 > are patents the beating heart of your boardroom?
PUBLICATIONS
European Biopharmaceutical Review

Are Patents the Beating Heart of your Boardroom?

Most companies do not yet understand that intellectual property (IP) is a lifeline in the brutally competitive world we now face. If you don't believe me here is a quick and easy way to determine the level of IP knowledge in your organisation.

Ask around your colleagues, or even better your boardroom, this simple question: how many years can a court enforce your patents, copyright and trademarks upon other companies?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ian Harvey, Chief Executive Officer of BTG plc and Chairman of the Government's Intellectual Property Advisory Committee

Ian Harvey is the CEO of BTG, a global technology commercialisation company. He is also Chairman of both the Intellectual Property Institute and the DTI's Intellectual Property Advisory Committee. He joined BTG in 1985 as Chief Executive having spent 10 years with Vickers and Laporte Industries and seven years with the World Bank. Between 1988 and 1993 he served as a member of the Prime Minister's Advisory Council on Science and Technology.

Ian is a Fellow of Nottingham University (1994), and a Member of the Advisory Panel for Science and Technology Policy Research of Sussex University (SPRU) since 1989. He has an MA in Mechanical Sciences from Cambridge University and an MBA from Harvard University.

spacer
Ian Harvey
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

3rd African Regulatory Conference (ARC)

3-4 May 2012, Accra, Ghana

The African Regulatory Conference offers the opportunity for key stakeholders active on the continent, including representatives from Ministry of Health, local and multinational pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
More info >>

 
News and Press Releases

APTAR PHARMA’S PRESERVATIVE-FREE MULTIDOSE DISPENSER OSD CHOSEN FOR THE FIRST TIME FOR AN EYE CARE PRODUCT

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) has found its first application for the treatment of dry eye with the launch of VISMED® MULTI. Aptar Pharma has worked closely with the Swiss-German based Eye Care specialist TRB Chemedica for improving patient safety, achieving dosing accuracy and maintaining product stability on the ophthalmic spray device.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.